As the lot number for the device was provided, a review of the device history records is currently being performed.The return of the sample is pending.However, a photo was provided for review.The investigation of the reported event is currently underway.(expiry date: 11/2022).
|
H10: manufacturing review: the device history records have been reviewed and this lot met all release criteria.There was nothing found to indicate there was a manufacturing related cause for this event.Investigation summary: one unsealed powerflow implantable port kit.The following components were received: one powerflow implantable apheresis iv port, one catheter, one flushing connector, one syringe, one tunneler, one introducer needle, one bd insyte autoguard shielded iv catheter, one cath-lock, one j-tip guidewire in a guidewire hoop, and one 10f introducer peel-apart sheath with vessel dilator were returned for evaluation.In addition to the returned physical device two electronic photos were provided for review.The investigation is confirmed for the reported unsealed device packaging issue as the outer and inner tyvek labels were returned completely separated from the tyvek tray and seal transfer was noted throughout the border of the tyvek tray.Furthermore, the bd insyte autoguard shielded iv catheter packaging was noted to be open.A tear was noted to a styrofoam padding.A corner of the tyvek label was noted to be teared.The photo and manufacturing review also confirms the same.The definitive root cause of this complaint could not be determined the cause of this condition remains unknown.Labeling review: a review of product labeling documentation (e.G., procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, nursing guide, and unit label) did not find any product labeling inadequacy.H10: d4 (expiry date: 11/2022), g3.H11: h6 (method, result, conclusion).H11:section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
|